Ligand Pharmaceuticals Reports Third Quarter Financial Results
The Jupiter-based company posted a quarterly loss of $28.5 million despite beating analyst revenue estimates.
Live Poll
Do you trust that quarterly earnings reports accurately reflect a company's long-term financial health?